1 Study Matches
Preventing de novo portal vein thrombosis with Antithrombin-III in patients with cirrhosis: A randomized, double-blinded, placebo - controlled trial (PiVoT-AC Trial)
Portal vein thrombosis (PVT) is blockage or narrowing of the portal vein (the blood vessel that brings blood to the liver from the intestines) by a blood clot. It is a common complication in patients with cirrhosis. There is an understanding that patients with cirrhosis are at higher risk for clotting events. This study will examine the use of antithrombin III (a protein found in the body) as a potential drug that may prevent blood clotting in patients with cirrhosis.
18 year(s) or older
Inclusion Criteria:Adults age ≥18 or ≤75 years
active Hepatitis C infection
recent major surgery within six weeks
Digestive Systems & Liver Disease